banner

FORTUNE

  • email
  • twitter
  • linkedin
  • facebook
Russia’s Sputnik V vaccine finally has manufacturing muscle
On Monday, Indian regulators approved Russia’s Sputnik V COVID-19 vaccine. Now, the state-backed Russian Direct Investment Fund (RDIF), which is...

An FDA change to vaccine authorization allowed Pfizer and Moderna to apply for BA.5 booster approval without key data
On Monday, Pfizer asked the U.S. Food and Drug Administration for emergency authorization for the drugmaker’s new Omicron booster targeting the...

Singapore is the latest country to approve Novavax's COVID vaccine while the U.S. reviews application
Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you. On Monday,...

If you have hemophilia, you can now get a one-time gene therapy for $3.5 million
U.S. health regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting...

China’s risky COVID-19 vaccine development strategy paid off
Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today. On Tuesday, the...

https://media.caboodleai.net/pda/companies/bd48f726-fb54-459e-990a-50e09bc2949a.x-icon

United States
Website: fortune.com